Revenio Group Oyj
HLSE-REG1V
Company Overview
Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; DRSplus, a device for detection of diabetic retinopathy; iCare MAIA, a microperimeter to measure the visual field; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. It also provides Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
Name
Revenio Group Oyj
CEO
Jouni Toijala
Website
www.reveniogroup.fi
Sector
Health Care Equipment and Supplies
Year Founded
2001
Company Statistics
Profile
Market Cap
—
EV
—
Shares Out
—
Revenue
—
Employees
—
Margins
Gross
—
EBITDA
—
Operating
—
Pre-Tax
—
Net
—
FCF
—
Returns (5Yr Avg)
ROA
—
ROTA
—
ROE
—
ROCE
—
ROIC
—
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
—
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
—
Net Debt
—
Debt/Equity
—
EBIT/Interest
—
Growth (CAGR)
Rev 3Yr
—
Rev 5Yr
—
Rev 10Yr
—
Dil EPS 3Yr
—
Dil EPS 5Yr
—
Dil EPS 10Yr
—
Rev Fwd 2Yr
—
EBITDA Fwd 2Yr
—
EPS Fwd 2Yr
—
EPS LT Growth Est
—
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—